Your browser doesn't support javascript.
loading
Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study.
Park, Sohee; Kim, Ju Hwan; Kim, Songhee; Kang, Jisu; Moon, Seoyoung; Kim, Seok Jin; Shin, Ju-Young.
Affiliation
  • Park S; Sungkyunkwan University School of Pharmacy, Seoul, South Korea.
  • Kim JH; Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.
  • Kim S; Sungkyunkwan University School of Pharmacy, Seoul, South Korea.
  • Kang J; Sungkyunkwan University School of Pharmacy, Seoul, South Korea.
  • Moon S; Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea.
  • Kim SJ; Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea.
  • Shin JY; Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea. kstwoh@skku.edu.
Blood Cancer J ; 13(1): 123, 2023 08 18.
Article in En | MEDLINE | ID: mdl-37591839
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Large B-Cell, Diffuse Type of study: Observational_studies Limits: Humans Language: En Journal: Blood Cancer J Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Lymphoma, Large B-Cell, Diffuse Type of study: Observational_studies Limits: Humans Language: En Journal: Blood Cancer J Year: 2023 Document type: Article Affiliation country: